nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—CYP2E1—type 2 diabetes mellitus	0.121	0.387	CbGaD
Azelastine—CYP1A2—type 2 diabetes mellitus	0.115	0.369	CbGaD
Azelastine—CYP3A4—type 2 diabetes mellitus	0.0761	0.244	CbGaD
Azelastine—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0251	0.0518	CbGbCtD
Azelastine—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0215	0.0443	CbGbCtD
Azelastine—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0185	0.0383	CbGbCtD
Azelastine—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0148	0.0306	CbGbCtD
Azelastine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0141	0.0291	CbGbCtD
Azelastine—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0134	0.0277	CbGbCtD
Azelastine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0132	0.0273	CbGbCtD
Azelastine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0129	0.0267	CbGbCtD
Azelastine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0126	0.0259	CbGbCtD
Azelastine—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0124	0.0255	CbGbCtD
Azelastine—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0119	0.0247	CbGbCtD
Azelastine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0118	0.0244	CbGbCtD
Azelastine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0112	0.0232	CbGbCtD
Azelastine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0112	0.0232	CbGbCtD
Azelastine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.011	0.0227	CbGbCtD
Azelastine—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0106	0.0218	CbGbCtD
Azelastine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0104	0.0214	CbGbCtD
Azelastine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.01	0.0207	CbGbCtD
Azelastine—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00974	0.0201	CbGbCtD
Azelastine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00958	0.0198	CbGbCtD
Azelastine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00935	0.0193	CbGbCtD
Azelastine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00935	0.0193	CbGbCtD
Azelastine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00908	0.0187	CbGbCtD
Azelastine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00863	0.0178	CbGbCtD
Azelastine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00855	0.0176	CbGbCtD
Azelastine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00844	0.0174	CbGbCtD
Azelastine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00833	0.0172	CbGbCtD
Azelastine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00789	0.0163	CbGbCtD
Azelastine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00762	0.0157	CbGbCtD
Azelastine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00754	0.0156	CbGbCtD
Azelastine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00752	0.0155	CbGbCtD
Azelastine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00713	0.0147	CbGbCtD
Azelastine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00709	0.0146	CbGbCtD
Azelastine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00688	0.0142	CbGbCtD
Azelastine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00679	0.014	CbGbCtD
Azelastine—CYP3A5—Losartan—type 2 diabetes mellitus	0.00653	0.0135	CbGbCtD
Azelastine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00648	0.0134	CbGbCtD
Azelastine—CYP2C8—Losartan—type 2 diabetes mellitus	0.00628	0.013	CbGbCtD
Azelastine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00624	0.0129	CbGbCtD
Azelastine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00621	0.0128	CbGbCtD
Azelastine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00601	0.0124	CbGbCtD
Azelastine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00576	0.0119	CbGbCtD
Azelastine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00544	0.0112	CbGbCtD
Azelastine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00527	0.0109	CbGbCtD
Azelastine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00486	0.01	CbGbCtD
Azelastine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00479	0.00988	CbGbCtD
Azelastine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00465	0.00959	CbGbCtD
Azelastine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00438	0.00904	CbGbCtD
Azelastine—ABCB1—Losartan—type 2 diabetes mellitus	0.00425	0.00877	CbGbCtD
Azelastine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00412	0.0085	CbGbCtD
Azelastine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00395	0.00815	CbGbCtD
Azelastine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00395	0.00815	CbGbCtD
Azelastine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00374	0.00771	CbGbCtD
Azelastine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00278	0.00574	CbGbCtD
Azelastine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00255	0.00525	CbGbCtD
Azelastine—Meclizine—CYP1A2—type 2 diabetes mellitus	0.00033	0.249	CrCbGaD
Azelastine—Clemastine—CYP3A4—type 2 diabetes mellitus	0.000206	0.155	CrCbGaD
Azelastine—Loxapine—ADRA2A—type 2 diabetes mellitus	0.00014	0.106	CrCbGaD
Azelastine—Loxapine—HTR2C—type 2 diabetes mellitus	0.000129	0.0972	CrCbGaD
Azelastine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000128	0.00105	CcSEcCtD
Azelastine—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000128	0.00105	CcSEcCtD
Azelastine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000127	0.00105	CcSEcCtD
Azelastine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000127	0.00104	CcSEcCtD
Azelastine—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000127	0.00104	CcSEcCtD
Azelastine—Discomfort—Orlistat—type 2 diabetes mellitus	0.000127	0.00104	CcSEcCtD
Azelastine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000126	0.00103	CcSEcCtD
Azelastine—Malaise—Metformin—type 2 diabetes mellitus	0.000125	0.00103	CcSEcCtD
Azelastine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000125	0.00103	CcSEcCtD
Azelastine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000125	0.00103	CcSEcCtD
Azelastine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000125	0.00103	CcSEcCtD
Azelastine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000125	0.00102	CcSEcCtD
Azelastine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000124	0.00102	CcSEcCtD
Azelastine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000124	0.00102	CcSEcCtD
Azelastine—Infection—Valsartan—type 2 diabetes mellitus	0.000124	0.00102	CcSEcCtD
Azelastine—Rash—Glipizide—type 2 diabetes mellitus	0.000124	0.00102	CcSEcCtD
Azelastine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000124	0.00102	CcSEcCtD
Azelastine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000124	0.00102	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000124	0.00102	CcSEcCtD
Azelastine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000123	0.00101	CcSEcCtD
Azelastine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000123	0.00101	CcSEcCtD
Azelastine—Headache—Glipizide—type 2 diabetes mellitus	0.000123	0.00101	CcSEcCtD
Azelastine—Palpitations—Metformin—type 2 diabetes mellitus	0.000123	0.00101	CcSEcCtD
Azelastine—Infection—Orlistat—type 2 diabetes mellitus	0.000122	0.00101	CcSEcCtD
Azelastine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000122	0.001	CcSEcCtD
Azelastine—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000122	0.001	CcSEcCtD
Azelastine—Tension—Losartan—type 2 diabetes mellitus	0.000121	0.000996	CcSEcCtD
Azelastine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000121	0.000995	CcSEcCtD
Azelastine—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000121	0.000994	CcSEcCtD
Azelastine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000121	0.000994	CcSEcCtD
Azelastine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000121	0.000992	CcSEcCtD
Azelastine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000121	0.000991	CcSEcCtD
Azelastine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000121	0.000991	CcSEcCtD
Azelastine—Hypertension—Metformin—type 2 diabetes mellitus	0.00012	0.000986	CcSEcCtD
Azelastine—Nervousness—Losartan—type 2 diabetes mellitus	0.00012	0.000986	CcSEcCtD
Azelastine—Back pain—Losartan—type 2 diabetes mellitus	0.000119	0.000982	CcSEcCtD
Azelastine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000119	0.000981	CcSEcCtD
Azelastine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000118	0.000974	CcSEcCtD
Azelastine—Chest pain—Metformin—type 2 diabetes mellitus	0.000118	0.000973	CcSEcCtD
Azelastine—Myalgia—Metformin—type 2 diabetes mellitus	0.000118	0.000973	CcSEcCtD
Azelastine—Malaise—Irbesartan—type 2 diabetes mellitus	0.000118	0.000972	CcSEcCtD
Azelastine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000118	0.000969	CcSEcCtD
Azelastine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000118	0.000968	CcSEcCtD
Azelastine—Clozapine—ADRA2A—type 2 diabetes mellitus	0.000117	0.0886	CrCbGaD
Azelastine—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000117	0.000963	CcSEcCtD
Azelastine—Discomfort—Metformin—type 2 diabetes mellitus	0.000117	0.000961	CcSEcCtD
Azelastine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000117	0.000961	CcSEcCtD
Azelastine—Nausea—Glipizide—type 2 diabetes mellitus	0.000117	0.000958	CcSEcCtD
Azelastine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000116	0.000957	CcSEcCtD
Azelastine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000116	0.000956	CcSEcCtD
Azelastine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000116	0.000954	CcSEcCtD
Azelastine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000116	0.000953	CcSEcCtD
Azelastine—Pain—Gliclazide—type 2 diabetes mellitus	0.000116	0.000953	CcSEcCtD
Azelastine—Rash—Glimepiride—type 2 diabetes mellitus	0.000115	0.000949	CcSEcCtD
Azelastine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000115	0.000948	CcSEcCtD
Azelastine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000115	0.000946	CcSEcCtD
Azelastine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000115	0.000945	CcSEcCtD
Azelastine—Headache—Glimepiride—type 2 diabetes mellitus	0.000115	0.000943	CcSEcCtD
Azelastine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000115	0.000941	CcSEcCtD
Azelastine—Cough—Irbesartan—type 2 diabetes mellitus	0.000114	0.000941	CcSEcCtD
Azelastine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000114	0.00094	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000113	0.000933	CcSEcCtD
Azelastine—Agitation—Losartan—type 2 diabetes mellitus	0.000113	0.000932	CcSEcCtD
Azelastine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000113	0.000931	CcSEcCtD
Azelastine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000113	0.000929	CcSEcCtD
Azelastine—Flushing—Ramipril—type 2 diabetes mellitus	0.000113	0.000928	CcSEcCtD
Azelastine—Infection—Metformin—type 2 diabetes mellitus	0.000113	0.000926	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000112	0.000922	CcSEcCtD
Azelastine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000112	0.000919	CcSEcCtD
Azelastine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000112	0.000918	CcSEcCtD
Azelastine—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000112	0.000918	CcSEcCtD
Azelastine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000112	0.000918	CcSEcCtD
Azelastine—Malaise—Losartan—type 2 diabetes mellitus	0.000111	0.000915	CcSEcCtD
Azelastine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000111	0.000915	CcSEcCtD
Azelastine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000111	0.000914	CcSEcCtD
Azelastine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000111	0.000913	CcSEcCtD
Azelastine—Vertigo—Losartan—type 2 diabetes mellitus	0.000111	0.000912	CcSEcCtD
Azelastine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000111	0.000911	CcSEcCtD
Azelastine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000111	0.00091	CcSEcCtD
Azelastine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000111	0.000909	CcSEcCtD
Azelastine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.00011	0.000907	CcSEcCtD
Azelastine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000109	0.000898	CcSEcCtD
Azelastine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000109	0.000898	CcSEcCtD
Azelastine—Palpitations—Losartan—type 2 diabetes mellitus	0.000109	0.000897	CcSEcCtD
Azelastine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000109	0.000894	CcSEcCtD
Azelastine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000108	0.000891	CcSEcCtD
Azelastine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000108	0.000891	CcSEcCtD
Azelastine—Clozapine—HTR2C—type 2 diabetes mellitus	0.000108	0.0816	CrCbGaD
Azelastine—Cough—Losartan—type 2 diabetes mellitus	0.000108	0.000885	CcSEcCtD
Azelastine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000107	0.000883	CcSEcCtD
Azelastine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000107	0.000881	CcSEcCtD
Azelastine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000107	0.000881	CcSEcCtD
Azelastine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000107	0.00088	CcSEcCtD
Azelastine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000107	0.000878	CcSEcCtD
Azelastine—Constipation—Valsartan—type 2 diabetes mellitus	0.000107	0.000876	CcSEcCtD
Azelastine—Infection—Irbesartan—type 2 diabetes mellitus	0.000106	0.000874	CcSEcCtD
Azelastine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000106	0.000872	CcSEcCtD
Azelastine—Pain—Orlistat—type 2 diabetes mellitus	0.000105	0.000865	CcSEcCtD
Azelastine—Chest pain—Losartan—type 2 diabetes mellitus	0.000105	0.000864	CcSEcCtD
Azelastine—Myalgia—Losartan—type 2 diabetes mellitus	0.000105	0.000864	CcSEcCtD
Azelastine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000105	0.000863	CcSEcCtD
Azelastine—Anxiety—Losartan—type 2 diabetes mellitus	0.000105	0.000861	CcSEcCtD
Azelastine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000104	0.000859	CcSEcCtD
Azelastine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000856	CcSEcCtD
Azelastine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000855	CcSEcCtD
Azelastine—Tension—Ramipril—type 2 diabetes mellitus	0.000104	0.000854	CcSEcCtD
Azelastine—Discomfort—Losartan—type 2 diabetes mellitus	0.000104	0.000854	CcSEcCtD
Azelastine—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000104	0.000852	CcSEcCtD
Azelastine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000103	0.000851	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000103	0.00085	CcSEcCtD
Azelastine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000103	0.000849	CcSEcCtD
Azelastine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000103	0.000845	CcSEcCtD
Azelastine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000103	0.000845	CcSEcCtD
Azelastine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000102	0.000837	CcSEcCtD
Azelastine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000102	0.000837	CcSEcCtD
Azelastine—Confusional state—Losartan—type 2 diabetes mellitus	0.000102	0.000835	CcSEcCtD
Azelastine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000101	0.000834	CcSEcCtD
Azelastine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000101	0.000831	CcSEcCtD
Azelastine—Somnolence—Metformin—type 2 diabetes mellitus	0.000101	0.000829	CcSEcCtD
Azelastine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000101	0.000828	CcSEcCtD
Azelastine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000101	0.000827	CcSEcCtD
Azelastine—Infection—Losartan—type 2 diabetes mellitus	0.0001	0.000823	CcSEcCtD
Azelastine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.99e-05	0.000821	CcSEcCtD
Azelastine—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.85e-05	0.000809	CcSEcCtD
Azelastine—Tachycardia—Losartan—type 2 diabetes mellitus	9.83e-05	0.000808	CcSEcCtD
Azelastine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	9.82e-05	0.000807	CcSEcCtD
Azelastine—Nausea—Bromocriptine—type 2 diabetes mellitus	9.81e-05	0.000806	CcSEcCtD
Azelastine—Fatigue—Metformin—type 2 diabetes mellitus	9.78e-05	0.000804	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	9.75e-05	0.000802	CcSEcCtD
Azelastine—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.73e-05	0.0008	CcSEcCtD
Azelastine—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.73e-05	0.0008	CcSEcCtD
Azelastine—Asthenia—Gliclazide—type 2 diabetes mellitus	9.73e-05	0.0008	CcSEcCtD
Azelastine—Agitation—Ramipril—type 2 diabetes mellitus	9.73e-05	0.0008	CcSEcCtD
Azelastine—Constipation—Metformin—type 2 diabetes mellitus	9.7e-05	0.000797	CcSEcCtD
Azelastine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	9.61e-05	0.00079	CcSEcCtD
Azelastine—Vomiting—Glyburide—type 2 diabetes mellitus	9.6e-05	0.000789	CcSEcCtD
Azelastine—Pruritus—Gliclazide—type 2 diabetes mellitus	9.59e-05	0.000788	CcSEcCtD
Azelastine—Malaise—Ramipril—type 2 diabetes mellitus	9.54e-05	0.000785	CcSEcCtD
Azelastine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	9.54e-05	0.000785	CcSEcCtD
Azelastine—Rash—Glyburide—type 2 diabetes mellitus	9.52e-05	0.000783	CcSEcCtD
Azelastine—Somnolence—Irbesartan—type 2 diabetes mellitus	9.51e-05	0.000782	CcSEcCtD
Azelastine—Dermatitis—Glyburide—type 2 diabetes mellitus	9.51e-05	0.000782	CcSEcCtD
Azelastine—Vertigo—Ramipril—type 2 diabetes mellitus	9.51e-05	0.000782	CcSEcCtD
Azelastine—Headache—Glyburide—type 2 diabetes mellitus	9.46e-05	0.000778	CcSEcCtD
Azelastine—Palpitations—Ramipril—type 2 diabetes mellitus	9.35e-05	0.000769	CcSEcCtD
Azelastine—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.35e-05	0.000768	CcSEcCtD
Azelastine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.27e-05	0.000763	CcSEcCtD
Azelastine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.27e-05	0.000762	CcSEcCtD
Azelastine—Cough—Ramipril—type 2 diabetes mellitus	9.23e-05	0.000759	CcSEcCtD
Azelastine—Fatigue—Irbesartan—type 2 diabetes mellitus	9.23e-05	0.000759	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	9.18e-05	0.000754	CcSEcCtD
Azelastine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	9.18e-05	0.000754	CcSEcCtD
Azelastine—Pain—Irbesartan—type 2 diabetes mellitus	9.15e-05	0.000752	CcSEcCtD
Azelastine—Constipation—Irbesartan—type 2 diabetes mellitus	9.15e-05	0.000752	CcSEcCtD
Azelastine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	9.07e-05	0.000745	CcSEcCtD
Azelastine—Paraesthesia—Losartan—type 2 diabetes mellitus	9.04e-05	0.000744	CcSEcCtD
Azelastine—Chest pain—Ramipril—type 2 diabetes mellitus	9.01e-05	0.000741	CcSEcCtD
Azelastine—Myalgia—Ramipril—type 2 diabetes mellitus	9.01e-05	0.000741	CcSEcCtD
Azelastine—Dyspnoea—Losartan—type 2 diabetes mellitus	8.98e-05	0.000738	CcSEcCtD
Azelastine—Anxiety—Ramipril—type 2 diabetes mellitus	8.98e-05	0.000738	CcSEcCtD
Azelastine—Nausea—Glyburide—type 2 diabetes mellitus	8.97e-05	0.000737	CcSEcCtD
Azelastine—Abdominal pain—Metformin—type 2 diabetes mellitus	8.97e-05	0.000737	CcSEcCtD
Azelastine—Dizziness—Gliclazide—type 2 diabetes mellitus	8.96e-05	0.000737	CcSEcCtD
Azelastine—Somnolence—Losartan—type 2 diabetes mellitus	8.95e-05	0.000736	CcSEcCtD
Azelastine—Asthenia—Valsartan—type 2 diabetes mellitus	8.94e-05	0.000735	CcSEcCtD
Azelastine—Discomfort—Ramipril—type 2 diabetes mellitus	8.9e-05	0.000732	CcSEcCtD
Azelastine—Asthenia—Orlistat—type 2 diabetes mellitus	8.83e-05	0.000726	CcSEcCtD
Azelastine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.82e-05	0.000725	CcSEcCtD
Azelastine—Pruritus—Valsartan—type 2 diabetes mellitus	8.81e-05	0.000724	CcSEcCtD
Azelastine—Dry mouth—Ramipril—type 2 diabetes mellitus	8.81e-05	0.000724	CcSEcCtD
Azelastine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.75e-05	0.00072	CcSEcCtD
Azelastine—Confusional state—Ramipril—type 2 diabetes mellitus	8.71e-05	0.000716	CcSEcCtD
Azelastine—Pruritus—Orlistat—type 2 diabetes mellitus	8.71e-05	0.000716	CcSEcCtD
Azelastine—Fatigue—Losartan—type 2 diabetes mellitus	8.68e-05	0.000714	CcSEcCtD
Azelastine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	8.64e-05	0.00071	CcSEcCtD
Azelastine—Vomiting—Gliclazide—type 2 diabetes mellitus	8.62e-05	0.000709	CcSEcCtD
Azelastine—Pain—Losartan—type 2 diabetes mellitus	8.61e-05	0.000708	CcSEcCtD
Azelastine—Constipation—Losartan—type 2 diabetes mellitus	8.61e-05	0.000708	CcSEcCtD
Azelastine—Clozapine—CYP2E1—type 2 diabetes mellitus	8.58e-05	0.0647	CrCbGaD
Azelastine—Rash—Gliclazide—type 2 diabetes mellitus	8.55e-05	0.000703	CcSEcCtD
Azelastine—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.54e-05	0.000702	CcSEcCtD
Azelastine—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.52e-05	0.000701	CcSEcCtD
Azelastine—Headache—Gliclazide—type 2 diabetes mellitus	8.49e-05	0.000698	CcSEcCtD
Azelastine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.46e-05	0.000696	CcSEcCtD
Azelastine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.46e-05	0.000696	CcSEcCtD
Azelastine—Tachycardia—Ramipril—type 2 diabetes mellitus	8.43e-05	0.000693	CcSEcCtD
Azelastine—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.42e-05	0.000692	CcSEcCtD
Azelastine—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.3e-05	0.000682	CcSEcCtD
Azelastine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.24e-05	0.000677	CcSEcCtD
Azelastine—Dizziness—Valsartan—type 2 diabetes mellitus	8.24e-05	0.000677	CcSEcCtD
Azelastine—Clozapine—CYP1A2—type 2 diabetes mellitus	8.16e-05	0.0615	CrCbGaD
Azelastine—Dizziness—Orlistat—type 2 diabetes mellitus	8.14e-05	0.000669	CcSEcCtD
Azelastine—Asthenia—Metformin—type 2 diabetes mellitus	8.14e-05	0.000669	CcSEcCtD
Azelastine—Nausea—Gliclazide—type 2 diabetes mellitus	8.05e-05	0.000662	CcSEcCtD
Azelastine—Pruritus—Metformin—type 2 diabetes mellitus	8.02e-05	0.00066	CcSEcCtD
Azelastine—Abdominal pain—Losartan—type 2 diabetes mellitus	7.96e-05	0.000655	CcSEcCtD
Azelastine—Body temperature increased—Losartan—type 2 diabetes mellitus	7.96e-05	0.000655	CcSEcCtD
Azelastine—Vomiting—Valsartan—type 2 diabetes mellitus	7.92e-05	0.000651	CcSEcCtD
Azelastine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.89e-05	0.000648	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.87e-05	0.000647	CcSEcCtD
Azelastine—Rash—Valsartan—type 2 diabetes mellitus	7.85e-05	0.000646	CcSEcCtD
Azelastine—Dermatitis—Valsartan—type 2 diabetes mellitus	7.85e-05	0.000645	CcSEcCtD
Azelastine—Vomiting—Orlistat—type 2 diabetes mellitus	7.82e-05	0.000643	CcSEcCtD
Azelastine—Headache—Valsartan—type 2 diabetes mellitus	7.8e-05	0.000641	CcSEcCtD
Azelastine—Diarrhoea—Metformin—type 2 diabetes mellitus	7.76e-05	0.000638	CcSEcCtD
Azelastine—Rash—Orlistat—type 2 diabetes mellitus	7.76e-05	0.000638	CcSEcCtD
Azelastine—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.76e-05	0.000638	CcSEcCtD
Azelastine—Dermatitis—Orlistat—type 2 diabetes mellitus	7.75e-05	0.000637	CcSEcCtD
Azelastine—Headache—Orlistat—type 2 diabetes mellitus	7.71e-05	0.000634	CcSEcCtD
Azelastine—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.7e-05	0.000633	CcSEcCtD
Azelastine—Asthenia—Irbesartan—type 2 diabetes mellitus	7.68e-05	0.000631	CcSEcCtD
Azelastine—Somnolence—Ramipril—type 2 diabetes mellitus	7.68e-05	0.000631	CcSEcCtD
Azelastine—Pruritus—Irbesartan—type 2 diabetes mellitus	7.57e-05	0.000623	CcSEcCtD
Azelastine—Dizziness—Metformin—type 2 diabetes mellitus	7.5e-05	0.000617	CcSEcCtD
Azelastine—Fatigue—Ramipril—type 2 diabetes mellitus	7.45e-05	0.000612	CcSEcCtD
Azelastine—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.42e-05	0.00061	CcSEcCtD
Azelastine—Nausea—Valsartan—type 2 diabetes mellitus	7.4e-05	0.000608	CcSEcCtD
Azelastine—Constipation—Ramipril—type 2 diabetes mellitus	7.39e-05	0.000607	CcSEcCtD
Azelastine—Prazepam—CYP3A4—type 2 diabetes mellitus	7.38e-05	0.0557	CrCbGaD
Azelastine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.32e-05	0.000602	CcSEcCtD
Azelastine—Nausea—Orlistat—type 2 diabetes mellitus	7.31e-05	0.000601	CcSEcCtD
Azelastine—Asthenia—Losartan—type 2 diabetes mellitus	7.23e-05	0.000594	CcSEcCtD
Azelastine—Vomiting—Metformin—type 2 diabetes mellitus	7.21e-05	0.000593	CcSEcCtD
Azelastine—Rash—Metformin—type 2 diabetes mellitus	7.15e-05	0.000588	CcSEcCtD
Azelastine—Dermatitis—Metformin—type 2 diabetes mellitus	7.14e-05	0.000587	CcSEcCtD
Azelastine—Pruritus—Losartan—type 2 diabetes mellitus	7.13e-05	0.000586	CcSEcCtD
Azelastine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.12e-05	0.000585	CcSEcCtD
Azelastine—Headache—Metformin—type 2 diabetes mellitus	7.11e-05	0.000584	CcSEcCtD
Azelastine—Dizziness—Irbesartan—type 2 diabetes mellitus	7.08e-05	0.000582	CcSEcCtD
Azelastine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000581	CcSEcCtD
Azelastine—Diarrhoea—Losartan—type 2 diabetes mellitus	6.89e-05	0.000567	CcSEcCtD
Azelastine—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.83e-05	0.000561	CcSEcCtD
Azelastine—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.83e-05	0.000561	CcSEcCtD
Azelastine—Vomiting—Irbesartan—type 2 diabetes mellitus	6.81e-05	0.000559	CcSEcCtD
Azelastine—Rash—Irbesartan—type 2 diabetes mellitus	6.75e-05	0.000555	CcSEcCtD
Azelastine—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.74e-05	0.000554	CcSEcCtD
Azelastine—Nausea—Metformin—type 2 diabetes mellitus	6.74e-05	0.000554	CcSEcCtD
Azelastine—Headache—Irbesartan—type 2 diabetes mellitus	6.71e-05	0.000551	CcSEcCtD
Azelastine—Dizziness—Losartan—type 2 diabetes mellitus	6.66e-05	0.000548	CcSEcCtD
Azelastine—Vomiting—Losartan—type 2 diabetes mellitus	6.4e-05	0.000527	CcSEcCtD
Azelastine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.36e-05	0.000523	CcSEcCtD
Azelastine—Nausea—Irbesartan—type 2 diabetes mellitus	6.36e-05	0.000523	CcSEcCtD
Azelastine—Rash—Losartan—type 2 diabetes mellitus	6.35e-05	0.000522	CcSEcCtD
Azelastine—Dermatitis—Losartan—type 2 diabetes mellitus	6.35e-05	0.000522	CcSEcCtD
Azelastine—Headache—Losartan—type 2 diabetes mellitus	6.31e-05	0.000519	CcSEcCtD
Azelastine—Asthenia—Ramipril—type 2 diabetes mellitus	6.2e-05	0.000509	CcSEcCtD
Azelastine—Pruritus—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000502	CcSEcCtD
Azelastine—Nausea—Losartan—type 2 diabetes mellitus	5.98e-05	0.000492	CcSEcCtD
Azelastine—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.91e-05	0.000486	CcSEcCtD
Azelastine—Dizziness—Ramipril—type 2 diabetes mellitus	5.71e-05	0.00047	CcSEcCtD
Azelastine—Vomiting—Ramipril—type 2 diabetes mellitus	5.49e-05	0.000451	CcSEcCtD
Azelastine—Rash—Ramipril—type 2 diabetes mellitus	5.45e-05	0.000448	CcSEcCtD
Azelastine—Dermatitis—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000447	CcSEcCtD
Azelastine—Headache—Ramipril—type 2 diabetes mellitus	5.41e-05	0.000445	CcSEcCtD
Azelastine—Clozapine—CYP3A4—type 2 diabetes mellitus	5.4e-05	0.0407	CrCbGaD
Azelastine—Nausea—Ramipril—type 2 diabetes mellitus	5.13e-05	0.000422	CcSEcCtD
Azelastine—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	2.63e-06	3.27e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	2.63e-06	3.27e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	2.62e-06	3.26e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—INS—type 2 diabetes mellitus	2.62e-06	3.25e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.62e-06	3.25e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	2.61e-06	3.25e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.61e-06	3.24e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	2.59e-06	3.22e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.59e-06	3.21e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.59e-06	3.21e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.58e-06	3.21e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.58e-06	3.21e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.58e-06	3.21e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	2.58e-06	3.21e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.58e-06	3.2e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.57e-06	3.2e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.57e-06	3.19e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.56e-06	3.18e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.56e-06	3.18e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.56e-06	3.18e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.55e-06	3.17e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	2.54e-06	3.16e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.54e-06	3.16e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.54e-06	3.16e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.54e-06	3.15e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.54e-06	3.15e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.53e-06	3.15e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.53e-06	3.15e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	2.53e-06	3.14e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.52e-06	3.13e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.52e-06	3.13e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.52e-06	3.13e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.52e-06	3.13e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.52e-06	3.13e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.5e-06	3.11e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.5e-06	3.11e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	2.5e-06	3.1e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.49e-06	3.1e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.48e-06	3.08e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	2.47e-06	3.07e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.46e-06	3.06e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.46e-06	3.06e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	2.45e-06	3.05e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.44e-06	3.04e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.44e-06	3.03e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.43e-06	3.03e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.43e-06	3.02e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.43e-06	3.02e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	2.42e-06	3.01e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	2.42e-06	3.01e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	2.41e-06	3e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	2.41e-06	2.99e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	2.41e-06	2.99e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.41e-06	2.99e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	2.4e-06	2.98e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.4e-06	2.98e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.4e-06	2.98e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.38e-06	2.95e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	2.37e-06	2.95e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	2.37e-06	2.95e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.37e-06	2.95e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	2.37e-06	2.95e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	2.37e-06	2.94e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.35e-06	2.92e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.34e-06	2.91e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.33e-06	2.9e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.33e-06	2.9e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.3e-06	2.86e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.3e-06	2.86e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.3e-06	2.85e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.3e-06	2.85e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.29e-06	2.85e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.29e-06	2.85e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.29e-06	2.85e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.28e-06	2.84e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	2.28e-06	2.84e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.28e-06	2.84e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.27e-06	2.83e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.26e-06	2.81e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.26e-06	2.81e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.26e-06	2.81e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.26e-06	2.81e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	2.25e-06	2.79e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	2.24e-06	2.78e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.23e-06	2.78e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	2.22e-06	2.76e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.22e-06	2.76e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.22e-06	2.75e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.21e-06	2.74e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.2e-06	2.74e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.2e-06	2.73e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.19e-06	2.72e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.19e-06	2.72e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.19e-06	2.72e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.19e-06	2.72e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.18e-06	2.71e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.18e-06	2.71e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	2.18e-06	2.7e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	2.17e-06	2.7e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	2.16e-06	2.69e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.15e-06	2.67e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.15e-06	2.67e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.15e-06	2.67e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.14e-06	2.66e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.14e-06	2.65e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.12e-06	2.64e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	2.12e-06	2.64e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.12e-06	2.63e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.12e-06	2.63e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.1e-06	2.61e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.1e-06	2.61e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.09e-06	2.6e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	2.09e-06	2.6e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.09e-06	2.59e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	2.08e-06	2.59e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.08e-06	2.59e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.08e-06	2.58e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.08e-06	2.58e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.08e-06	2.58e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	2.08e-06	2.58e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	2.08e-06	2.58e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.07e-06	2.57e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.07e-06	2.57e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.06e-06	2.56e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	2.05e-06	2.55e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	2.05e-06	2.55e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.04e-06	2.54e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.04e-06	2.54e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.03e-06	2.52e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.01e-06	2.5e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.99e-06	2.48e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.99e-06	2.48e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.98e-06	2.46e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.97e-06	2.45e-05	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.97e-06	2.45e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	1.96e-06	2.44e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.96e-06	2.44e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.96e-06	2.44e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.96e-06	2.44e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.96e-06	2.44e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.96e-06	2.43e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.95e-06	2.43e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.95e-06	2.42e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.95e-06	2.42e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.95e-06	2.42e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.94e-06	2.42e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	1.94e-06	2.42e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.94e-06	2.41e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.93e-06	2.4e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	1.9e-06	2.37e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	1.9e-06	2.36e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.89e-06	2.35e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	1.88e-06	2.34e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.87e-06	2.32e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.87e-06	2.32e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.84e-06	2.29e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.83e-06	2.28e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.82e-06	2.27e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.82e-06	2.26e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.8e-06	2.24e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	1.8e-06	2.24e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.79e-06	2.23e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.79e-06	2.23e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.79e-06	2.22e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.79e-06	2.22e-05	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.78e-06	2.21e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.76e-06	2.19e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.76e-06	2.19e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.75e-06	2.18e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.72e-06	2.13e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.7e-06	2.12e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.7e-06	2.12e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.7e-06	2.11e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.69e-06	2.1e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.69e-06	2.1e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.68e-06	2.09e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.68e-06	2.09e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.68e-06	2.09e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.68e-06	2.08e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.67e-06	2.08e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.67e-06	2.07e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.67e-06	2.07e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.66e-06	2.06e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.65e-06	2.06e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.65e-06	2.05e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.65e-06	2.05e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	1.65e-06	2.04e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.64e-06	2.04e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.62e-06	2.01e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.61e-06	2e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.61e-06	2e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.61e-06	2e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.57e-06	1.95e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.57e-06	1.95e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.57e-06	1.95e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.54e-06	1.92e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.54e-06	1.91e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.54e-06	1.91e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.53e-06	1.9e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.52e-06	1.89e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.51e-06	1.87e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.5e-06	1.86e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.5e-06	1.86e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.49e-06	1.85e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.48e-06	1.84e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.48e-06	1.84e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.47e-06	1.83e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.46e-06	1.82e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.46e-06	1.82e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.46e-06	1.82e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.45e-06	1.81e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.44e-06	1.79e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.43e-06	1.78e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.43e-06	1.77e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.38e-06	1.72e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.37e-06	1.71e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.36e-06	1.69e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.35e-06	1.68e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.35e-06	1.67e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.34e-06	1.66e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.32e-06	1.63e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.31e-06	1.63e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.29e-06	1.61e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.29e-06	1.6e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.27e-06	1.58e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.25e-06	1.55e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.25e-06	1.55e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	1.21e-06	1.5e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.14e-06	1.42e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.14e-06	1.42e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.12e-06	1.4e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.1e-06	1.37e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.06e-06	1.31e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.04e-06	1.29e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.01e-06	1.25e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	9.77e-07	1.21e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	9.66e-07	1.2e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	9.66e-07	1.2e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	9.57e-07	1.19e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.56e-07	1.19e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	9.55e-07	1.19e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	9.02e-07	1.12e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	8.83e-07	1.1e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	8.27e-07	1.03e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	7.38e-07	9.17e-06	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	7.2e-07	8.95e-06	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	6.79e-07	8.44e-06	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	6.73e-07	8.36e-06	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	5.75e-07	7.15e-06	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	4.44e-07	5.52e-06	CbGpPWpGaD
